Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rocuronium vs Succinylcholine for Cesarean Section
NCT01941628Phase 4Completed
- Sponsor
- Charles University
- Start
- Aug 2014
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of rocuronium in cesarean section (2 arms), sponsored by Charles University. Primary endpoints: Induction to Delivery Interval at 24 hours, Number of Participants With Newborn in Need of Respiratory Support at 24 hours and 1 more. Started Aug 2014; status: completed.
02
Drugs
rocuronium
03
Conditions
cesarean section
Beyond the preview
Go deeper on NCT01941628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01941628.